Also trades as: 2126.HK (HKSE) · $vol 0M
JWCTF OTC
JW (Cayman) Therapeutics Co. Ltd
1W: +0.0%
1M: +0.0%
3M: -14.8%
YTD: -43.8%
1Y: -58.9%
3Y: -56.6%
$0.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$333M
+16.3% ▲
Capital Expenditures
$15M
-5.8% ▼
5Y CAGR: -31.5%
Free Cash Flow
-$349M
+15.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$249M
+34.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1.7B | -$702M | -$846M | -$768M | -$591M |
| Depreciation & Amort. | $23M | $46M | $81M | $100M | $90M |
| Stock-Based Comp. | $134M | $89M | $83M | $35M | $37M |
| Change in Working Capital | $17M | $50M | -$14M | $3M | -$30M |
| Other Non-Cash Items | $1.4B | $16M | $228M | $232M | $160M |
| Operating Cash Flow | -$261M | -$561M | -$537M | -$398M | -$333M |
| — Investing Activities — | |||||
| Capital Expenditures | -$124M | -$73M | -$77M | -$12M | -$5M |
| Acquisitions (Net) | $45M | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$24M | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$13M | -$64M | -$24M | $22M | -$10M |
| Investing Cash Flow | -$92M | -$137M | -$124M | $10M | -$15M |
| — Financing Activities — | |||||
| Net Debt Issuance | $49M | -$13M | $135M | $28M | $119M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$39M | -$18M | -$23M | -$27M | -$28M |
| Financing Cash Flow | $2.9B | -$31M | $112M | $275K | $90M |
| Net Change in Cash | $2.4B | -$796M | -$451M | -$377M | -$249M |
| Cash End of Period | $2.6B | $1.8B | $1.4B | $1.0B | $757M |
| Free Cash Flow | -$385M | -$634M | -$614M | -$413M | -$349M |